Xenon - XENE Total Stockholders' Equity

Official company branding of Xenon (XENE)

Xenon Pharmaceuticals (XENE) is currently focusing on completing the final stages of trials for its epilepsy medications prior to their commercial launch. The business relies on scientific alliances with leading neurological centers to combat CNS pathologies, and the 1.25 metric complements the overall picture. The price action shown below confirms that partnerships with global behemoths are accelerating the validation of new molecules, creating powerful scientific synergy.

XENE: Xenon Book Capitalization 07/04/2022 - 10/29/2026

XENE (Xenon): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Share Price Xenon Corp|XENE - Analyst Consensus Forecast
- issuer market value details:
Market Value Xenon Pharmaceuticals Inc.|XENE - Total Company Value
- company book value details:
Equity per Share Xenon Pharmaceuticals|XENE - Book Capitalization|Market-to-Book Ratio xenon-pharma.com|XENE - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Xenon Pharmaceuticals|XENE - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Xenon Pharmaceuticals Inc.|XENE - Company Debts|Debts to Book Value Xenon Pharmaceuticals Inc.|XENE - Company Long-Term Liabilities|Company Short-Term Indebtedness Xenon Pharmaceuticals
Initial company analysis:XENE, Xenon Corp
Mass-produced product of Xenon Pharmaceuticals Inc.

Book value represents the net value of equity minus all liabilities, reflecting the actual asset backing of each share. By analyzing the firm's book value history, an investor assesses the financial stability of Xenon Pharmaceuticals (XENE), where the stability of this asset confirms the company's ability to scale robotic screening and AI modeling to accelerate the development of neurotherapeutic products.

Direct competitors

BIIB (Biogen Idec) - Accounting Capitalization|NBIX: Book Capitalization|Total Stockholders' Equity regencellbioscience.com (RGC)|Company Book Value Axsome Therapeutics, Inc.|Accounting Capitalization ACAD (ACADIA Pharma)|Book Capitalization VKTX|SUPN - Total Stockholders' Equity|Catalyst Pharmaceuticals - Company Net Assets|Book Capitalization denalitherapeutics.com DNLI|HRMY - Company Book Value|Accounting Value of Company BHVN (Biohaven Ltd)|Amylyx (AMLX) - Company Book Value|Total Stockholders' Equity Trevi Corp (TRVI)|Company Net Assets PRAX|Accounting Capitalization AVXL (anavex.com)|Book Capitalization CBLL|PRTA - Total Stockholders' Equity|Company Book Value Alector ALEC|ANNX: Accounting Capitalization|OMER - Company Book Value|Total Stockholders' Equity neurogene.com|AC Immune SA (ACIU) - Company Book Value|Accounting Capitalization VYGR|Company Net Assets NMRA|SCLX: Accounting Value of Company|Company Book Value Tevogen Bio Holdings (TVGN)|ACOG: Net Asset Value|Book Capitalization CGTX (Cognition Therapeutics)|Accounting Value of Company IKT|Cassava - Book Capitalization|ASRT - Book Capitalization|coyatherapeutics.com (COYA) - Company Book Value|Vistagen - Accounting Value of Company|Company Book Value Ovid Therapeutics Inc|Company Net Assets Acumen Pharmaceuticals Inc. (ABOS)|Book Capitalization CRVO|Book Capitalization alteritytherapeutics.com (ATHE)|Book Capitalization CLNN (Clene)|PEPG - Company Net Assets|Jupiter Neurosciences Inc - Book Capitalization|Total Stockholders' Equity Relmada Therapeutics Inc|ANVS (Annovis Bio Corp) - Company Net Assets|Grace Therapeutics (GRCE) - Book Capitalization|Company Net Assets AIFF|KLTO (ANEW Medical, Inc.) - Total Net Assets|Book Capitalization NRSN|Book Valuation of Business Reviva Pharmaceuticals Holdings Inc.|Book Capitalization MTVA (MetaVia)|NRXS - Company Net Assets|Helius Medical Technologies Inc. - Book Capitalization|PASG - Book Capitalization|bionomics.com.au (NEUP) - Company Book Value|NERV (Minerva Neurosciences Inc) - Company Book Value|Company Book Value Athira|Addex (ADXN) - Book Valuation of Business|Company Net Assets ALZN (Alzamend Neuro, Inc.)|cyclerion.com - Accounting Capitalization|Book Capitalization PTIX (Protagenic Therapeutics, Inc.)|Pasithea Therapeutics Corp (KTTA) - Total Stockholders' Equity|CRGT - Company Book Value|ATXI (Avenue Therapeutics Inc) - Accounting Capitalization|BCLI: Book Capitalization|Total Stockholders' Equity caratherapeutics.com (CARA)|Company Book Value Chromocell Therapeutics Corp.|Accounting Capitalization ELYM (Eliem)|Book Capitalization ITCI|LBPH - Total Stockholders' Equity|Marinus Pharmaceuticals - Company Net Assets|Book Capitalization nkgenbiotech.com NKGN|NRBO - Company Book Value|Accounting Value of Company SAGE (Sage Therapeutics Inc.)|Neurotrope (SNPX) - Company Book Value|Total Stockholders' Equity Trevena Inc (TRVN)|Company Net Assets VIGL|Accounting Capitalization WENA (Anew Medical Inc.)|Book Capitalization CERE